Insights

Insight
September 2021

H.R. 3 is the Wrong Policy for the Wrong Problem

Insight
September 2021

OHE is Launching a New Series to Explore the Latest Attempts to Reduce the Cost of US Healthcare

Insight
July 2021

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Insight
June 2021

Towards a New Understanding of Unmet Medical Need

Insight
June 2021

Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

Insight
April 2021

Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?

Insight
April 2021

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Insight
April 2021

Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?

Insight
March 2021

Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System

Insight
March 2021

Time to Tackle the Challenges around Combination Therapies for Cancer

Insight
March 2021

Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains

Newsroom

The latest news and comment from OHE experts

Read Now

Subscribe To Our Newsletter

Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.

News and Insights

Latest Research & Publications

An Analysis of NICE’s Optimised Decisions from 2015 to 2024

Analysing Global Immunisation Expenditure

The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

Establishing the Economic Value of Carbon-Minimal Inhalers

The Importance of Diversity of Supply in Rare Diseases Markets

2023 OHE Annual Report to the Charity Commission

Employer Costs from Respiratory Infections

All Publications

Filter results by

Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool

R&D For New Drugs To Tackle AMR Is A High Return Investment For All EU Member States

Filter results by

H.R. 3 is the Wrong Policy for the Wrong Problem

OHE is Launching a New Series to Explore the Latest Attempts to Reduce the Cost of US Healthcare

How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?

Towards a New Understanding of Unmet Medical Need

Allocating Public Spending Efficiently: Is There a Need for a Better Mechanism to Inform Decisions in the UK and Elsewhere?

Would Waiving COVID-19 Vaccines Patents Save Lives?

Cost-Effectiveness Thresholds and Expert Elicitation: a Bridge Too Far?

Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic

Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?

Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System

Time to Tackle the Challenges around Combination Therapies for Cancer

Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains

Newsroom

Subscribe To Our Newsletter

Share on Mastodon